Vir Biotechnology (VIR) Current Taxes (2021 - 2023)

Vir Biotechnology has disclosed Current Taxes across 3 years of filings, most recently posting $15.3 million for Q1 2023.

• Current Taxes for Q1 2023 came in at $15.3 million, down 96.23% year-over-year; the trailing twelve-month figure through Mar 2023 was $15.3 million (down 96.23% YoY), and the FY2022 annual result was $15.2 million, up 144.94% from the prior year.
• Current Taxes came in at $15.3 million for Q1 2023 at Vir Biotechnology, roughly flat from $15.2 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $404.4 million in Q1 2022 to a low of $6.2 million in Q4 2021.
• The 3-year median for Current Taxes is $56.7 million (2022), against an average of $116.1 million.
• Across the five-year window, Current Taxes surged 144.94% in 2022 and tumbled 96.23% in 2023, its largest moves.
• Vir Biotechnology's Current Taxes stood at $6.2 million in 2021, then surged by 144.94% to $15.2 million in 2022, then increased by 0.16% to $15.3 million in 2023.
• The last three Current Taxes figures came in at $15.3 million (Q1 2023), $15.2 million (Q4 2022), and $98.2 million (Q3 2022), per Business Quant data.